Atara Biotherapeutics Stock Forecast

Evaluation of Atara Biotherapeutics stock downgraded after the last trading session.
(Updated on Apr 25, 2024)

ATRA Signals & Forecast

There are few to no technical positive signals at the moment. The Atara Biotherapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.701. On a fall, the stock will find some support from the short-term average at $0.700. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, February 02, 2024, and so far it has fallen -42.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Atara Biotherapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Atara Biotherapeutics stock

Atara Biotherapeutics finds support from accumulated volume at $0.697 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0600 between high and low, or 9.09%. For the last week, the stock has had daily average volatility of 8.25%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ATRA) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Atara Biotherapeutics to open at $0.693, and during the day (based on 14 day Average True Range), to move between $0.636 and $0.763, which gives a possible trading interval of +/-$0.0634 (+/-9.07%) up or down from last closing price. If Atara Biotherapeutics takes out the full calculated possible swing range there will be an estimated 18.13% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.697 (0.34%) than the resistance at $0.762 (8.82%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Atara Biotherapeutics stock A Buy?

Atara Biotherapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -3.272 Sell Candidate Downgraded

Predicted Opening Price for Atara Biotherapeutics of Friday, April 26, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.